retatrutide clinical trials obesity trial access Perceived benefits of treatment for with retatrutide: A qualitative study of patients in a phase 2 What Are the New Weight – Clinical trial for chronic obesity

Ferro et al., 2024

A UT Southwestern study published in JAMA Network Open in March 2026 found that only 25% of patients remained on any GLP-1 receptor agonist one year after starting therapy

Symes, Recent progress towards the electrosynthesis of ammonia from sustainable resources

this includes chlorambucil (adduct formation through nucleophilic substitution of the atom of chlorine [118]), cyclophosphamide (acrolein is one its main metabolites conjugating to GSH and becoming significantly less cytotoxic than the parent compound [119]), mitomycin C (forming mono- and bis-conjugates with GSH to be detoxified [120]), and various tyrosine kinases inhibitors (such as axitinib and sunitinib [121])

Colorimetric determination of glutathione in human serum and cell lines by exploiting the peroxidase-like activity of CuS-polydopamine-Au composite

For total ATP content measurements, cells were lysed with CellTiter-Glo Reagent (Promega Corporation, Madison, WI, USA) and total ATP determined